Miller Dieker syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
In particular, deletion of PAFAH1B1 causes isolated lissencephaly while deletions involving both PAFAH1B1 and YWHAE cause Miller-Dieker syndrome.
|
23035971 |
2012 |
Miller Dieker syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Examination of cerebral spinal fluid in humans suggests that 14-3-3s including 14-3-3ε (YWHAE) are up-regulated in several neurological diseases, and loss or duplication of the YWHAE gene leads to Miller-Dieker syndrome.
|
22811265 |
2012 |
Miller Dieker syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Deletions of the PAFAH1B1 gene (encoding LIS1) in 17p13.3 result in isolated lissencephaly sequence, and extended deletions including the YWHAE gene (encoding 14-3-3epsilon) cause Miller-Dieker syndrome.
|
19136950 |
2009 |
Miller Dieker syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
We have created a physical map covering approximately 3.5 Mb (6 cM)in this region, spanning the RP13 interval and extending distally to the gene MDCR (formerly, LIS1), which, when deleted, leads to the MDLS phenotype.
|
10828595 |
2000 |
Miller Dieker syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Six different genes could be responsible for this entity (LIS1, DCX, TUBA1A, VLDLR, ARX, RELN), although co-delection of YWHAE gene with LIS1 could result in Miller-Dieker Syndrome.
|
19120042 |
2009 |
Miller Dieker syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Her facial features are similar to MDS, and she has manifestations seen in other cases with YWHAE duplication.
|
23633430 |
2013 |
Miller Dieker syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Miller-Dieker syndrome (MDS) is caused by a heterozygous deletion of chromosome 17p13.3 involving the genes LIS1 and YWHAE (coding for 14.3.3ε) and leads to malformations during cortical development.
|
28380362 |
2017 |
Schizophrenia
|
0.450 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia.
|
28991256 |
2017 |
Schizophrenia
|
0.450 |
GeneticVariation
|
disease |
GWASCAT |
Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.
|
30285260 |
2019 |
Schizophrenia
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
These results suggest a possible role for the YWHAE genotype in the early development of the OFC sulcogyral pattern, but its effect alone is not likely to explain the altered sulcogyral pattern in schizophrenia.
|
24561237 |
2014 |
Endometrial Stromal Sarcoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Endometrial stromal sarcomas (ESSs) frequently harbor genetic fusions, including JAZF1-SUZ12 and equivalent fusions in low-grade ESS (LGESS) and YWHAE-NUTM2 in high-grade ESS (HGESS).
|
25288234 |
2014 |
Endometrial Stromal Sarcoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Tumors with YWHAE-FAM22 rearrangements constitute a distinct group of ESS, which is associated with high-grade morphology and aggressive clinical behavior compared to JAZF1 ESS.
|
22456610 |
2012 |
Endometrial Stromal Sarcoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In an update based on the 2014 WHO classification, low-grade ESS is often associated with gene rearrangement bringing about the JAZF 1-SUZ12 (formerly JAZF1-JJAZ1) fusion gene, whereas high-grade ESS is associated with the YWHAE-NUTM fusion gene.
|
29660202 |
2018 |
Endometrial Stromal Sarcoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Collectively, these findings suggest that abnormality in the loci of YWHAE, FAM22A and FAM22B, which are known to be associated with oncogenesis of endometrial stromal sarcoma, may contribute to the development of uterine angiosarcoma.
|
24125656 |
2014 |
Endometrial Stromal Sarcoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We examined YWHAE rearrangements by FISH break-apart and RT-PCR in a series of 27 undifferentiated uterine stromal sarcoma without JAZF1 rearrangements.
|
23599159 |
2013 |
Endometrial Stromal Sarcoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Tumors with YWHAE-NUTM2 fusions and BCOR genetic abnormalities showed morphology characteristic of high-grade endometrial stromal sarcomas.
|
30789359 |
2019 |
Endometrial Stromal Sarcoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Immunohistochemically, the high-grade round cell component of all 12 YWHAE-FAM22 ESS demonstrated diffuse (≥70%) moderate to strong nuclear cyclin D1 staining, and this diffuse positivity was not seen in 34 ESSs with JAZF1 and equivalent genetic rearrangements or in 21 low-grade ESS with no demonstrable genetic rearrangements.
|
22982899 |
2012 |
Clear cell sarcoma of kidney
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
A third 'double-negative' (DN) category comprises CCSKs with neither BCOR ITDs nor YWHAE-NUTM2 fusion.
|
28833375 |
2018 |
Clear cell sarcoma of kidney
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Until now, the sole recurrent genetic aberration identified in CCSKs is t(10;17)(q22;p13), which gives rise to a fusion transcript of YWHAE and NUTM2B/E.
|
26542179 |
2016 |
Clear cell sarcoma of kidney
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
The remaining cases and control group lacked YWHAE gene rearrangements; instead, consistent BCOR ITDs, similar to CCSK, were found in 15/29 (52%) infantile sarcoma cases (9/22 infantile URCS and 6/7 PMMTI).
|
26945340 |
2016 |
Clear cell sarcoma of kidney
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, BCOR immunohistochemical stain is a highly sensitive marker for SBRCTs and CCSKs with BCOR abnormalities and YWHAE-rearrangements and can be used as a useful diagnostic marker in these various molecular subsets.
|
27428733 |
2016 |
Clear cell sarcoma of kidney
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Mutually exclusive BCOR internal tandem duplications and YWHAE-NUTM2 fusions in clear cell sarcoma of kidney: not the full story.
|
27000436 |
2016 |
Clear cell sarcoma of kidney
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
However, there is a subset of CCSKs that do not harbor either the BCOR-ITD or YWHAE-NUTM2 translocation and lack known molecular alterations.
|
28440018 |
2017 |
Neoplasm Metastasis
|
0.340 |
GeneticVariation
|
phenotype |
BEFREE |
However, high-grade ESS with metastasis with YWHAE rearrangement shows a relatively favorable prognosis.
|
29660202 |
2018 |
Global developmental delay
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
While deletion of chromosome 17p13.3 (encompassing PAFAH1B1 and YWHAE genes) is known to result in Miller-Dieker syndrome (OMIM 247200), 17p13.3 microduplication gives rise to a condition commonly associated with developmental delay and autism spectrum disorder.
|
23063769 |
2012 |